Skip to main content
SpringerLink
Log in

Association of osteopontin and tumor necrosis factor-α levels with insulin resistance in obese patients with obstructive sleep apnea syndrome

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Objective: The aims of this study were to compare the tumor necrosis factor (TNF)-α and osteopontin levels, to identify the relationship between insulin resistance (IR) and osteopontin levels in obese patients with and without obstructive sleep apnea syndrome (OSAS). Method: The study population included 62 obese patients (35 males, 27 females) with OSAS and was compared with 26 obese patients (16 males, 10 females) without OSAS as a control group. Polysomnographic evaluation, spirometric tests and arterial blood gas sampling were performed on the obese patients with OSAS. Plasma levels of TNF-α and osteopontin were measured by enzyme-linked immunosorbent assays during the process. IR was estimated using the homeostasis model assessment (HOMA). Results: Mean plasma levels of fasting glucose, insulin, HOMA, liver function test, hematocrit, leukocyte, TSH, free T4, fibrinogen, TNF-α, and osteopontin were similar in the 2 groups. In patients with OSAS, mean osteopontin levels were positively correlated with mean fasting insulin levels (r=0.306, p=0.01), HOMA (r=0.299, p=0.01), apnea-hypopnea index (r=0.377, p=0.03) and Epworth Sleepiness Scale (r=0.299, p=0.01). However, mean TNF-α levels were negatively correlated with Epworth Sleepiness Scale (r=-0.298, p=0.01) in the patients with OSAS. Conclusions: It was observed that TNF-α and osteopontin levels showed no difference between obese patients with and without OSAS. However, osteopontin levels increased with fasting insulin, IR, OSAS severity, and daytime sleepiness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Inancli HM, Enoz M. Obstructive sleep apnea syndrome and upper airway inflammation. Recent Pat Inflamm Allergy Drug Discov 2010, 4: 54–7.

    Article  PubMed  Google Scholar 

  2. Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 2008, 177: 369–75.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Otake K, Sasanabe R, Hasegawa R, et al. Glucose intolerance in Japanese patients with obstructive sleep apnea. Intern Med 2009, 48: 1863–8.

    Article  PubMed  Google Scholar 

  4. Harsch IA, Wallaschofski H, Koebnick C, et al. Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance. Respiration 2004, 71: 580–6.

    Article  PubMed  Google Scholar 

  5. Harsch IA, Koebnick C, Wallaschofski H, et al. Resistin levels in patients with obstructive sleep apnea syndrome-the link to subclinical inflammation? Med Sci Monit 2004, 10: CR510–5.

    PubMed  Google Scholar 

  6. Makino S, Handa H, Suzukawa K, et al. Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 2006, 64: 12–9.

    Article  Google Scholar 

  7. Liu H, Liu J, Xiong S, Shen G, Zhang Z, Xu Y. The change of interleukin-6 and tumor necrosis factor in patients with obstructive sleep apnea syndrome. J Tongji Med Univ 2000, 20: 200–2.

    Article  PubMed  Google Scholar 

  8. Ciftci TU, Kokturk O, Bukan N, Bilgihan A. The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 2004, 28: 87–91.

    Article  PubMed  Google Scholar 

  9. Vgontzas AN, Papanicolaou DA, Bixler EO. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997, 82: 1313–6.

    Article  PubMed  Google Scholar 

  10. O’Regan AW, Nau GJ, Chupp GL, Berman JS. Osteopontin (Eta-1) in cell-medicated immunity: teaching an old dog new tricks. Immunol Today 2000, 21: 475–8.

    Article  PubMed  Google Scholar 

  11. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J 1993, 7: 1475–82.

    PubMed  Google Scholar 

  12. Trayhurn P, Wang B, Wood IS. Hypoxia and the endocrine and signalling role of white adipose tissue. Arch Physiol Biochem 2008, 114: 267–76.

    Article  PubMed  Google Scholar 

  13. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991, 14: 540–5.

    PubMed  Google Scholar 

  14. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring for sleep stages of human subjects. Los Angeles: Brain Information Service/Brain Research Institute, University of California, 1968.

    Google Scholar 

  15. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999, 22: 667–89.

    Google Scholar 

  16. Mohn A, Marcovecchio M, Chiarelli F. Validity of HOMA-IR as index of insulin resistance in obesity. J Pediatr 2006, 148: 565–6.

    Article  PubMed  Google Scholar 

  17. Jun J, Polotsky VY. Metabolic consequences of sleep-disordered breathing. ILAR J 2009, 50: 289–306.

    Article  PubMed  Google Scholar 

  18. Vgontzas AN, Papanicolaou DA, Bixler EO. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000, 85: 1151–8.

    Article  PubMed  Google Scholar 

  19. Naldini A, Leali D, Pucci A, et al. Cutting edge: IL-1 beta mediates the proangiogenic activity of osteopontin-activated human monocytes. J Immunol 2006, 177: 4267–70.

    PubMed  Google Scholar 

  20. Yu XQ, Fan JM, Nikolic-Paterson DJ, et al. IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. Am J Pathol 1999, 154: 833–41.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Noda M, Nagao M, Hanyu R, Miyai K, Ezura Y. Bone fracture and the healing mechanisms. Molecular bases of fracture healing. Clin Calcium 2009, 19: 634–40.

    PubMed  Google Scholar 

  22. Chaplet M, Waltregny D, Detry C, Fisher LW, Castronovo V, Bellahcène A. Expression of dentin sialophosphoprotein in human prostate cancer and its correlation with tumor aggressiveness. Int J Cancer 2006, 118: 850–6.

    Article  PubMed  Google Scholar 

  23. Xue S, Shen D, Gao H, Wang Y. Simple obesity is associated with reduced breast arterial calcification and increased plasma osteopontin level. Arch Med Res 2008, 39: 607–9.

    Article  PubMed  Google Scholar 

  24. Nomiyama T, Perez-Tilve D, Ogawa D, et al. Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice. J Clin Invest 2007, 117: 2877–88.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Bertola A, Deveaux V, Bonnafous S, et al. Elevated expression of osteopontin may be related to adipose tissue macrophage accumulation and liver Steatosis in morbid obesity. Diabetes 2009, 58: 125–33.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Gómez-Ambrosi J, Catalán V, Ramírez B, et al. Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J Clin Endocrinol Metab 2007, 92: 3719–27.

    Article  PubMed  Google Scholar 

  27. Schaller G, Aso Y, Schernthaner GH, et al. Increase of osteopontin plasma concentrations after bariatric surgery independent from inflammation and insulin resistance. Obes Surg 2009, 19: 351–6.

    Article  PubMed  Google Scholar 

  28. Takabatake N, Nakamura H, Abe S, et al. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000, 161: 1179–84.

    Article  PubMed  Google Scholar 

  29. Dyugovskaya L, Lavie P, Lavie L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 2003, 168: 242–9.

    Article  PubMed  Google Scholar 

  30. Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci 2005, 1051: 340–50.

    Article  PubMed  Google Scholar 

  31. Dyugovskaya L, Polyakov A, Lavie P, Lavie L. Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 2008, 177: 544–54.

    Article  PubMed  Google Scholar 

  32. Kanbay A, Kokturk O, Ciftci TU, Tavil Y, Bukan N. Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome. Respiration 2008, 76: 324–30.

    Article  PubMed  Google Scholar 

  33. Li Y, Chongsuvivatwong V, Geater A, Liu A. Are biomarker levels a good follow-up tool for evaluating obstructive sleep apnea syndrome treatments? Respiration 2008, 76: 317–23.

    Article  PubMed  Google Scholar 

  34. Alberti A, Sarchielli P, Gallinella E, et al. Plasma cytokine levels in patients with obstructive sleep apnea syndrome: A preliminary study. J Sleep Res 2003, 12: 305–11.

    Article  PubMed  Google Scholar 

  35. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. Clin Endocrinol Metab 2000, 85: 1151–8.

    Article  Google Scholar 

  36. Yao SM, Zhang XL. Association between residual sleepiness and central sleep apnea events in patients with obstructive sleep apnea syndrome. Zhonghua Jie He He Hu Xi Za Zhi 2008, 31: 664–9.

    PubMed  Google Scholar 

  37. Makino S, Fujiwara M, Suzukawa K, et al. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome. Horm Metab Res 2009, 41: 221–6.

    Article  PubMed  Google Scholar 

  38. Stoohs RA, Facchini F, Guilleminault C. Insulin resistance and sleep disordered breathing in health humans. Am J Respir Crit Care Med 1996, 154: 170–4.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Geriatrics, Ege University Medical Faculty, 5th Floor, Bornova, Izmir, 35100, Turkey

    F. Sarac MD, H. Bayrak & F. Akcicek

  2. Department of Chest Diseases, Ege University Medical Faculty, Izmir, Turkey

    O. K. Basoglu

  3. Department of Medical Biology, Ege University Medical Faculty, Izmir, Turkey

    C. Gunduz & C. Biray Avci

Authors
  1. F. Sarac MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. K. Basoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Gunduz
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Bayrak
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Biray Avci
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Akcicek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Sarac MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarac, F., Basoglu, O.K., Gunduz, C. et al. Association of osteopontin and tumor necrosis factor-α levels with insulin resistance in obese patients with obstructive sleep apnea syndrome. J Endocrinol Invest 34, 528–533 (2011). https://doi.org/10.3275/7287

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/7287

Key-words

Search

Navigation